Hygromycin B - Wikipedia
Hygromycin B is an antibiotic produced by the bacterium Streptomyces hygroscopicus. It is an aminoglycoside that kills bacteria, fungi and other eukaryotic cells by inhibiting protein synthesis. [1]
Hygromycin B (50 mg/mL) - Thermo Fisher Scientific
Hygromycin B is a water-soluble antibiotic purified from the bacterium Streptomyces hydroscopicus. Gibco™ Hygromycin B is used as a bacterial selection antibiotic in the concentration range of 200–500 μg/mL. This product is supplied as a 50 mg/mL solution.
From Discovery to Reality: Hygromycin A Moves to Human Trials
Hygromycin A, a potential breakthrough in Lyme disease treatment, is moving to human clinical trials in 2024. Take a journey through the timeline of how we got here, and how these trials could revolutionize Lyme research.
A targeted antibiotic for treating Lyme disease
2021年11月2日 · Researchers found that a neglected antibiotic called hygromycin A selectively kills the bacteria that cause Lyme disease. The antibiotic was able to treat Lyme disease in mice without disrupting the microbiome.
Hygromycin A: Antibiotic to Prevent Chronic Lyme
2023年5月30日 · Hygromycin A is the antibiotic being investigated in preventing chronic Lyme, and the game changing advantage is that this antibiotic targets and selectively kills Lyme disease-causing bacteria without damaging other beneficial bacteria in a person’s gut microbiome.
Hygromycin B is an aminoglycoside antibiotic which targets both prokaryotic and eukaryotic cells. Hygromycin B is freely soluble in water (50 mg/mL). Hygromycin B can be used to select for a...
Hygromycin B: Uses, Interactions, Mechanism of Action
2016年2月26日 · Hygromycin B is an aminoglycoside antibiotic produced by the bacterium Streptomyces hygroscopicus which kills bacteria, fungi and higher eukaryotic cells by inhibiting protein synthesis. Be among the first to try our new AI-powered, game-changing platform.
A selective antibiotic for Lyme disease - Cell Press
2021年10月6日 · Hygromycin A effectively clears an infection in mice by oral administration and had a minimal effect on the gut microbiome. These properties make hygromycin A an attractive candidate for developing an antibiotic for targeted treatment of Lyme disease.
Hygromycin B - an overview | ScienceDirect Topics
Hygromycin B is an aminocyclitol antibiotic inhibitor of protein synthesis with a broad spectrum activity against prokaryotes and eukaryotes. In plants, the antibiotic is very toxic.
Hygromycin B | C20H37N3O13 | CID 56928061 - PubChem
Hygromycin B is an aminoglycoside antibiotic produced by the bacterium Streptomyces hygroscopicus which kills bacteria, fungi and higher eukaryotic cells by inhibiting protein synthesis.